Compound 1449
Identifiers
- Canonical SMILES:
CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12)C(=O)NCCN1CCOCC1
- IUPAC name:
(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-(2-morpholin-4-ylethyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide
- InChi:
InChI=1S/C29H35Cl2FN4O3/c1-28(2,3)16-22-29(19-8-7-17(30)15-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-9-10-36-11-13-39-14-12-36/h4-8,15,22-23,25,35H,9-14,16H2,1-3H3,(H,33,37)(H,34,38)/t22-,23+,25-,29-/m1/s1
- InChiKey:
YTBYOWZWBDYLQF-WJCHFDDQSA-N
External links
![]() 132550165 |
MI6 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.77 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 576.21 g/mol | |||
HBA | 7 | |||
HBD | 3 | |||
HBA + HBD | 10 | |||
AlogP | 4.47 | |||
TPSA | 82.70 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19928922 | 1 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 7.55 | |
19928922 | 1 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.77 | |
19928922 | 1 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | SJSA-1 cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.30 |
19928922 | 1 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | Saos-2 cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.85 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8708 | SAR-405838 | DB12541 | |
0.7689 | Milademetan | DB15257 | |
0.5734 | Idasanutlin | DB12325 | |
0.5360 | Degarelix | DB06699 | |
0.5306 | SLV-334 | DB15356 | |
0.5300 | Daglutril | DB05796 | |
0.5147 | Acyline | DB11906 | |
0.5127 | Benazepril | DB00542 | |
0.5096 | Abarelix | DB00106 | |
0.5022 | Daptomycin | DB00080 | |
0.4923 | Mosapramine | DB13676 | |
0.4896 | Benazeprilat | DB14125 | |
0.4868 | Diamino-N-[(4S)-5-anilino-4-{[(2S)-2-{[(1R)-1-carboxyethyl]amino}-4-phenylbutanoyl]amino}-5-oxopentyl]methaniminium | DB02747 | |
0.4808 | MK-3207 | DB12424 | |
0.4798 | OPC-14523 | DB05422 |